AbCellera Investor Presentation Deck

STRATEGIC FUNDING UPDATE COPYRIGHT © ABCELLERA AbCellera secures $222M (CA$300M) non-dilutive funding to accelerate execution of strategy and bring pre-partnered programs into clinic Government co-investment is non-dilutive and provides certainty for accelerated strategy execution with high capital efficiency ● ● Total $519 million (CA$701 million) co- investment, AbCellera contribution $296 million (CA$401 million) Government contribution is mix of 20% grant, 55% success-contingent repayable, and 25% unconditionally repayable funds (unsecured debt) Funding drawn as investments are made, extending existing long cash runway FUNDING SOURCES $296M AbCellera $519M $167M Strategic Innovation Fund (Federal) $56M BC Investments will further strengthen leading engine to discover and develop antibody therapies, from target to patients - and do so in Canada ● Accelerate build-out of fully- integrated capabilities from target into Phase 1 trials Quickly leverage and demonstrate late-stage pre-clinical capability investments with pre-partnered programs Generate experience in and beneficial learnings from taking programs into the clinic PROJECT INVESTMENTS $224M Lab & Office Construction stronger engine $193M Drug Candidate R&D $519M $102M Clinical Studies enhanced portfolio Funding additional pre- partnered programs will enhance size and value of portfolio of stakes in future antibody therapies in multiple ways ● Initiate up to 17 programs with initial focus on cancer and immune disease Advance multiple programs through Phase 1, yielding clinical assets for partnering Strengthen program economics by visibly adding value from target into clinic As a result, AbCellera will be an even stronger company, propelling antibody-based medicines from target to clinic with precision and speed ● ● May 24th, 2023 ● Fully integrated target-to- patient capabilities at scale will be fully in place Track record of taking programs through Phase 1 will be robustly established Portfolio will be expanded with deep economic stakes in advanced programs Already substantial liquidity runway will be significantly extended

View entire presentation